Icon

KEFLET (nda050440)- (EQ 500MG BASE,EQ 1GM BASE,EQ 250MG BASE)

CEPHALEXIN LILLY
EQ 500MG BASE,EQ 1GM BASE,EQ 250MG BASE
No No
Expired Expired
None None
None No
Cephalexin tablets are indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Respiratory tract infections caused by susceptible isolates of Streptococcus pneumoniae and Streptococcus pyogenes Otitis media due to susceptible isolates of Streptococcu pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Moraxella Catarrhalis. Skin and skin structure infections caused by susceptible isolates of the following Gram-positive bacteria: Staphylococcus aureus, and Streptococcus pyogenes. Bone infections caused by susceptible isolates of Staphylococcus aureus and Proteus Mirabilis. Genitourinary tract infections, including acute prostatitis, caused by susceptible isolates of Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniare.
4 0 4
Total Other Developers None
Drugs with Suitability No
EQ 500MG BASE ** ** - 1 -
EQ 1GM BASE ** ** - - -
EQ 250MG BASE ** ** - - 1
NDA Sales Available Total Generic Sales Available
No 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* ****** *** ********* ****** ******* *********** ****-**, **. **.***/** & ***/**, ******* *******, ********** ******, ***** ***** ********, **********, ********* ******, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** **** **. ***/*, ***, ***/*, ***/* & ***/* ******* ****** ***** *****, *******, *****, ***** & *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.